The pharmacy briefing

News & insight.

Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.

Province

2 results

Health Canada Sets Guardrails for Decentralized Clinical Trials

Health Canada’s new guidance explains how existing drug-trial rules apply when visits, consent, data collection or investigational-product delivery move beyond traditional research sites. The update gives community health professionals a clearer view of their possible role—and the safeguards that remain.

Nov 3, 2026 · 4 min read Read briefing

Photo by pharmasist.ca

Clinical Research

Lilly Reports Phase 3 Retatrutide Results Against Semaglutide in Type 2 Diabetes

Eli Lilly says its investigational weekly retatrutide reduced A1c and body weight more than semaglutide 2 mg in an 80-week, open-label Phase 3 trial. Full results are not yet peer-reviewed, and retatrutide is not approved for routine use.

Nov 3, 2026 · 4 min read Read briefing

Photo by pharmasist.ca